Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.
Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH, Girondo MA, Rosenberg AL, Hooke JA, Kovatich AJ, Shriver CD, Rimm DL, Magliocco AM, Hyslop T, Rui H. Peck AR, et al. Among authors: kovatich aj. Breast Cancer Res. 2012 Oct 4;14(5):R130. doi: 10.1186/bcr3328. Breast Cancer Res. 2012. PMID: 23036105 Free PMC article.
HYOU1/Orp150 expression in breast cancer.
Stojadinovic A, Hooke JA, Shriver CD, Nissan A, Kovatich AJ, Kao TC, Ponniah S, Peoples GE, Moroni M. Stojadinovic A, et al. Among authors: kovatich aj. Med Sci Monit. 2007 Nov;13(11):BR231-239. Med Sci Monit. 2007. PMID: 17968289
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer.
Witkiewicz AK, Dasgupta A, Nguyen KH, Liu C, Kovatich AJ, Schwartz GF, Pestell RG, Sotgia F, Rui H, Lisanti MP. Witkiewicz AK, et al. Among authors: kovatich aj. Cancer Biol Ther. 2009 Jun;8(11):1071-9. doi: 10.4161/cbt.8.11.8874. Epub 2009 Jun 29. Cancer Biol Ther. 2009. PMID: 19502809 Free article.
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
Peck AR, Witkiewicz AK, Liu C, Stringer GA, Klimowicz AC, Pequignot E, Freydin B, Tran TH, Yang N, Rosenberg AL, Hooke JA, Kovatich AJ, Nevalainen MT, Shriver CD, Hyslop T, Sauter G, Rimm DL, Magliocco AM, Rui H. Peck AR, et al. Among authors: kovatich aj. J Clin Oncol. 2011 Jun 20;29(18):2448-58. doi: 10.1200/JCO.2010.30.3552. Epub 2011 May 16. J Clin Oncol. 2011. PMID: 21576635 Free PMC article.
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.
Sato T, Tran TH, Peck AR, Girondo MA, Liu C, Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs SY, Rui H. Sato T, et al. Among authors: kovatich aj. Oncogene. 2014 Apr 24;33(17):2215-24. doi: 10.1038/onc.2013.172. Epub 2013 May 27. Oncogene. 2014. PMID: 23708665 Free PMC article.
Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.
Goodman CR, Sato T, Peck AR, Girondo MA, Yang N, Liu C, Yanac AF, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H. Goodman CR, et al. Among authors: kovatich aj. Oncogene. 2016 Mar 17;35(11):1373-85. doi: 10.1038/onc.2015.193. Epub 2015 Jun 22. Oncogene. 2016. PMID: 26096934 Free PMC article.
103 results